Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine
2017 · Scientific Reports · 57 citations
https://doi.org/10.1038/s41598-017-04250-2
F
Feng Mao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
125
Papers
2.0K
Citations
24
h-index
49
i10-index
Feng Mao is an academic researcher from Ningbo University. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Breast Lesions and Carcinomas. The author has an h-index of 24, co-authored 107 publications.
ORCID: 0000-0003-0969-817XPapers by this author
worksEvaluation of the quality and readability of online information about breast cancer in China
2020 · Patient Education and Counseling · 47 citations
https://doi.org/10.1016/j.pec.2020.09.012
Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer
2021 · Cell Death and Disease · 40 citations
https://doi.org/10.1038/s41419-021-03917-z
Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer
2019 · Scientific Reports · 30 citations
https://doi.org/10.1038/s41598-019-47118-3
Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014)
2016 · Oncotarget · 26 citations
https://doi.org/10.18632/oncotarget.8778
Validation of CTS5 model in large-scale breast cancer population and the impact of menopausal and HER2 status on its prognostic value
2020 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-020-61648-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat